Development of activated endothelial targeted high-density lipoprotein nanoparticles

Development of activated endothelial targeted high-density lipoprotein nanoparticles

Endothelial inflammation is an important pathophysiological driving force in various acute and chronic inflammatory diseases. High-density lipoproteins (HDLs) play critical roles in regulating endothelial functions and resolving endothelial inflammation. In the present study, we developed synthetic...

Full description

Bibliographic Details
Main Authors: Minzhi Yu, Kristen Hong, Reheman Adili, Ling Mei, Lisha Liu, Hongliang He, Yanhong Guo, Y. Eugene Chen, Michael Holinstat, Anna Schwendeman
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Pharmacology
Subjects:
VCAM-1
endothelium
inflammation
anti-inflammation
high-density lipoprotein
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.902269/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.902269/full

Similar Items